Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study of Caesarean Section Births in a Tertiary Care Hospital in Mumbai Using Robson Classification System.

Journal of obstetrics and gynaecology of India·2024
Same author

Labial Fusion in an Adult Female: An Interesting Case.

Journal of obstetrics and gynaecology of India·2023
Same author

Conjoined Twins: A Rare Entity.

Journal of obstetrics and gynaecology of India·2022
Same author

Causes and Demographic Factors Affecting Stillbirth in a Tertiary Care Centre in India.

Journal of obstetrics and gynaecology of India·2022
Same author

OHVIRA Syndrome (Obstructed Hemivagina with Ipsilateral Renal Agenesis).

Journal of obstetrics and gynaecology of India·2021
Same author

Laparoscopic Uterovaginal Anastomosis for Cervical Agenesis.

Journal of obstetrics and gynaecology of India·2020

Related Experiment Video

Updated: Jun 13, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.3K

Staging of Cervical Cancer: What has Changed?

Pradnya Changede1

  • 1Department of Obstetrics & Gynaecology, LTMMC & GH, Sion, Mumbai, Maharashtra India.

Journal of Obstetrics and Gynaecology of India
|September 16, 2024
PubMed
Summary

The 2024 revised FIGO staging for cervical cancer improves accuracy by incorporating imaging and pathology for tumor size and lymph node assessment. This updated approach aims to reduce treatment errors and enhance patient outcomes for women diagnosed with cervical cancer.

Keywords:
Cancer cervix stagingFIGO 2018 staging cancer cervixFIGO classification Cancer cervixRevised 2024 staging cancer cervixSurgical staging cancer cervix

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.4K

Related Experiment Videos

Last Updated: Jun 13, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.3K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.4K

Area of Science:

  • Gynecology
  • Oncology
  • Pathology

Background:

  • Cervical cancer is a significant global health issue, particularly in India, where it's the second leading cause of cancer death.
  • Traditional clinical staging for cervical cancer had limitations in accurately assessing tumor size and lymph node involvement, leading to treatment errors and increased morbidity.
  • Previous staging systems, like the 2009 FIGO approach, often resulted in patients requiring adjuvant therapy after initial treatment based on clinical findings.

Purpose of the Study:

  • To outline the key changes and advantages of the 2024 revised International Federation of Gynecology and Obstetrics (FIGO) staging guidelines for cervical cancer.
  • To highlight the integration of imaging and pathological assessments into the new staging criteria.
  • To emphasize the improved categorization of tumor size and lymph node involvement for more precise staging.

Main Methods:

  • The 2024 revised FIGO guidelines incorporate pathological and imaging modalities alongside clinical diagnosis for staging cervical cancer.
  • Tumor size is now stratified into three subgroups: IB1 (≤2 cm), IB2 (>2–≤4 cm), and IB3 (>4 cm).
  • Lymph node involvement is classified based on pathology (p) or imaging (r), with a new Stage IIIC category for pelvic (IIIC1) and para-aortic (IIIC2) node involvement.

Main Results:

  • The revised staging system provides a more accurate estimation of disease extent by including imaging and pathology.
  • The new classification addresses limitations of previous methods, particularly in determining lymph node status.
  • Pathological assessment is prioritized over radiological and clinical findings for definitive staging.

Conclusions:

  • The 2024 revised FIGO staging for cervical cancer offers significant advantages, including better tumor and lymph node assessment, leading to more accurate prognostication.
  • This updated staging system aims to minimize treatment-related morbidity by reducing errors in initial treatment planning.
  • Further research is needed to validate the efficacy of the revised staging in diverse populations.